AffiAB® Anti-NAPSIN A Antibody [A9B12]
Napsin-A is an aspartic proteinase that is encoded in humans by the NAPSA gene. The name napsin comes from novel aspartic proteinase of the pepsin family. The activation peptide of an aspartic proteinase acts as an inhibitor of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus. Detection of NAPSA gene expression can be used to distinguish adenocarcinomas from other forms of lung cancer.
Antibody type
Mouse monoclonal Antibody
Uniprot ID
SwissProt: O96009 Human
Recombinant
NO
Conjugation
Non-conjugated
Host
Mouse
Isotype
IgG2a
Clone
A9B12
KO/KD
N/A
Species reactivity
Human
Tested applications
IHC-P
Predicted species reactivity
N/A
Immunogen
Recombinant protein within human NAPSIN A aa 51-200 / 420.
Storage
Store at +4°C after thawing. Aliquot store at -20°C. Avoid repeated freeze / thaw cycles.
Form
Liquid
Storage buffer
PBS (pH7.4) , 0.1% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration
2 mg/mL.
Purity
Protein A affinity purified.
Signal pathway
N/A
Recommended dilutions
IHC-P: 1:1, 000
Molecular Weight
Predicted band size: 45 kDa
Subcellular location
Secreted.
Positive control
Human kidney tissue, human lung carcinoma tissue.